Kim, S. M., Lee, B., An, H. J., Kim, D. H., Park, K. C., Noh, S., . . . Chung, H. Y. (2017). Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging. Oncotarget.
استشهاد بنمط شيكاغوKim, Seong Min, et al. "Novel PPARα Agonist MHY553 Alleviates Hepatic Steatosis By Increasing Fatty Acid Oxidation and Decreasing Inflammation During Aging." Oncotarget 2017.
MLA استشهادKim, Seong Min, et al. "Novel PPARα Agonist MHY553 Alleviates Hepatic Steatosis By Increasing Fatty Acid Oxidation and Decreasing Inflammation During Aging." Oncotarget 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.